nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefprozil—Superinfection—Fluorouracil—colon cancer	0.0688	0.0688	CcSEcCtD
Cefprozil—Superinfection—Capecitabine—colon cancer	0.0481	0.0481	CcSEcCtD
Cefprozil—Tonsillitis—Capecitabine—colon cancer	0.0432	0.0432	CcSEcCtD
Cefprozil—Developmental delay—Fluorouracil—colon cancer	0.0411	0.0411	CcSEcCtD
Cefprozil—Congenital anomaly—Fluorouracil—colon cancer	0.0411	0.0411	CcSEcCtD
Cefprozil—Congenital anomaly—Capecitabine—colon cancer	0.0287	0.0287	CcSEcCtD
Cefprozil—Developmental delay—Capecitabine—colon cancer	0.0287	0.0287	CcSEcCtD
Cefprozil—Prothrombin level increased—Capecitabine—colon cancer	0.0266	0.0266	CcSEcCtD
Cefprozil—Pruritus genital—Capecitabine—colon cancer	0.0261	0.0261	CcSEcCtD
Cefprozil—Colitis—Irinotecan—colon cancer	0.0157	0.0157	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Irinotecan—colon cancer	0.0125	0.0125	CcSEcCtD
Cefprozil—Colitis—Capecitabine—colon cancer	0.0105	0.0105	CcSEcCtD
Cefprozil—Pancytopenia—Vincristine—colon cancer	0.00998	0.00998	CcSEcCtD
Cefprozil—Neutropenia—Vincristine—colon cancer	0.00982	0.00982	CcSEcCtD
Cefprozil—Eosinophilia—Fluorouracil—colon cancer	0.0097	0.0097	CcSEcCtD
Cefprozil—Neutropenia—Irinotecan—colon cancer	0.00957	0.00957	CcSEcCtD
Cefprozil—Pancytopenia—Fluorouracil—colon cancer	0.00931	0.00931	CcSEcCtD
Cefprozil—Haemolytic anaemia—Capecitabine—colon cancer	0.00878	0.00878	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Capecitabine—colon cancer	0.0084	0.0084	CcSEcCtD
Cefprozil—Haemoglobin—Irinotecan—colon cancer	0.00823	0.00823	CcSEcCtD
Cefprozil—Haemorrhage—Irinotecan—colon cancer	0.00819	0.00819	CcSEcCtD
Cefprozil—Agranulocytosis—Fluorouracil—colon cancer	0.00815	0.00815	CcSEcCtD
Cefprozil—Vaginal inflammation—Methotrexate—colon cancer	0.00813	0.00813	CcSEcCtD
Cefprozil—Haemoglobin—Fluorouracil—colon cancer	0.00788	0.00788	CcSEcCtD
Cefprozil—Haemorrhage—Fluorouracil—colon cancer	0.00784	0.00784	CcSEcCtD
Cefprozil—Pharyngitis—Fluorouracil—colon cancer	0.00779	0.00779	CcSEcCtD
Cefprozil—Vaginal infection—Methotrexate—colon cancer	0.00767	0.00767	CcSEcCtD
Cefprozil—Aplastic anaemia—Methotrexate—colon cancer	0.00763	0.00763	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00714	0.00714	CcSEcCtD
Cefprozil—Erythema—Fluorouracil—colon cancer	0.00683	0.00683	CcSEcCtD
Cefprozil—Agitation—Vincristine—colon cancer	0.00673	0.00673	CcSEcCtD
Cefprozil—Pancytopenia—Capecitabine—colon cancer	0.0065	0.0065	CcSEcCtD
Cefprozil—Neutropenia—Capecitabine—colon cancer	0.0064	0.0064	CcSEcCtD
Cefprozil—Convulsion—Vincristine—colon cancer	0.00634	0.00634	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Methotrexate—colon cancer	0.00625	0.00625	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00605	0.00605	CcSEcCtD
Cefprozil—Anaphylactic shock—Vincristine—colon cancer	0.00597	0.00597	CcSEcCtD
Cefprozil—Convulsion—Fluorouracil—colon cancer	0.00592	0.00592	CcSEcCtD
Cefprozil—Confusional state—Irinotecan—colon cancer	0.00587	0.00587	CcSEcCtD
Cefprozil—Thrombocytopenia—Vincristine—colon cancer	0.00585	0.00585	CcSEcCtD
Cefprozil—Anaphylactic shock—Irinotecan—colon cancer	0.00582	0.00582	CcSEcCtD
Cefprozil—Agranulocytosis—Capecitabine—colon cancer	0.0057	0.0057	CcSEcCtD
Cefprozil—Thrombocytopenia—Irinotecan—colon cancer	0.0057	0.0057	CcSEcCtD
Cefprozil—Confusional state—Fluorouracil—colon cancer	0.00562	0.00562	CcSEcCtD
Cefprozil—Anaphylactic shock—Fluorouracil—colon cancer	0.00557	0.00557	CcSEcCtD
Cefprozil—Haemoglobin—Capecitabine—colon cancer	0.00551	0.00551	CcSEcCtD
Cefprozil—Haemorrhage—Capecitabine—colon cancer	0.00548	0.00548	CcSEcCtD
Cefprozil—Thrombocytopenia—Fluorouracil—colon cancer	0.00546	0.00546	CcSEcCtD
Cefprozil—Pharyngitis—Capecitabine—colon cancer	0.00544	0.00544	CcSEcCtD
Cefprozil—Insomnia—Vincristine—colon cancer	0.0054	0.0054	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00531	0.00531	CcSEcCtD
Cefprozil—Insomnia—Irinotecan—colon cancer	0.00526	0.00526	CcSEcCtD
Cefprozil—Erythema multiforme—Capecitabine—colon cancer	0.00518	0.00518	CcSEcCtD
Cefprozil—Somnolence—Irinotecan—colon cancer	0.00517	0.00517	CcSEcCtD
Cefprozil—Pain—Vincristine—colon cancer	0.00511	0.00511	CcSEcCtD
Cefprozil—Eosinophilia—Methotrexate—colon cancer	0.00505	0.00505	CcSEcCtD
Cefprozil—Insomnia—Fluorouracil—colon cancer	0.00504	0.00504	CcSEcCtD
Cefprozil—Pain—Irinotecan—colon cancer	0.00498	0.00498	CcSEcCtD
Cefprozil—Somnolence—Fluorouracil—colon cancer	0.00495	0.00495	CcSEcCtD
Cefprozil—Gastrointestinal pain—Vincristine—colon cancer	0.00489	0.00489	CcSEcCtD
Cefprozil—Pancytopenia—Methotrexate—colon cancer	0.00484	0.00484	CcSEcCtD
Cefprozil—Feeling abnormal—Irinotecan—colon cancer	0.00479	0.00479	CcSEcCtD
Cefprozil—Erythema—Capecitabine—colon cancer	0.00477	0.00477	CcSEcCtD
Cefprozil—Neutropenia—Methotrexate—colon cancer	0.00477	0.00477	CcSEcCtD
Cefprozil—Pain—Fluorouracil—colon cancer	0.00477	0.00477	CcSEcCtD
Cefprozil—Gastrointestinal pain—Irinotecan—colon cancer	0.00476	0.00476	CcSEcCtD
Cefprozil—Abdominal pain—Vincristine—colon cancer	0.00472	0.00472	CcSEcCtD
Cefprozil—Body temperature increased—Vincristine—colon cancer	0.00472	0.00472	CcSEcCtD
Cefprozil—Body temperature increased—Irinotecan—colon cancer	0.0046	0.0046	CcSEcCtD
Cefprozil—Abdominal pain—Irinotecan—colon cancer	0.0046	0.0046	CcSEcCtD
Cefprozil—Feeling abnormal—Fluorouracil—colon cancer	0.00459	0.00459	CcSEcCtD
Cefprozil—Drowsiness—Methotrexate—colon cancer	0.00455	0.00455	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00451	0.00451	CcSEcCtD
Cefprozil—Urticaria—Fluorouracil—colon cancer	0.00443	0.00443	CcSEcCtD
Cefprozil—Body temperature increased—Fluorouracil—colon cancer	0.00441	0.00441	CcSEcCtD
Cefprozil—Hypersensitivity—Vincristine—colon cancer	0.0044	0.0044	CcSEcCtD
Cefprozil—Hypersensitivity—Irinotecan—colon cancer	0.00429	0.00429	CcSEcCtD
Cefprozil—Agranulocytosis—Methotrexate—colon cancer	0.00424	0.00424	CcSEcCtD
Cefprozil—Hypersensitivity—Fluorouracil—colon cancer	0.00411	0.00411	CcSEcCtD
Cefprozil—Haemoglobin—Methotrexate—colon cancer	0.0041	0.0041	CcSEcCtD
Cefprozil—Diarrhoea—Vincristine—colon cancer	0.00409	0.00409	CcSEcCtD
Cefprozil—Haemorrhage—Methotrexate—colon cancer	0.00408	0.00408	CcSEcCtD
Cefprozil—Pharyngitis—Methotrexate—colon cancer	0.00405	0.00405	CcSEcCtD
Cefprozil—Diarrhoea—Irinotecan—colon cancer	0.00398	0.00398	CcSEcCtD
Cefprozil—Dizziness—Vincristine—colon cancer	0.00395	0.00395	CcSEcCtD
Cefprozil—Pruritus—Fluorouracil—colon cancer	0.00394	0.00394	CcSEcCtD
Cefprozil—Confusional state—Capecitabine—colon cancer	0.00393	0.00393	CcSEcCtD
Cefprozil—Erythema multiforme—Methotrexate—colon cancer	0.00386	0.00386	CcSEcCtD
Cefprozil—Dizziness—Irinotecan—colon cancer	0.00385	0.00385	CcSEcCtD
Cefprozil—Diarrhoea—Fluorouracil—colon cancer	0.00381	0.00381	CcSEcCtD
Cefprozil—Thrombocytopenia—Capecitabine—colon cancer	0.00381	0.00381	CcSEcCtD
Cefprozil—Vomiting—Vincristine—colon cancer	0.0038	0.0038	CcSEcCtD
Cefprozil—Rash—Vincristine—colon cancer	0.00377	0.00377	CcSEcCtD
Cefprozil—Dermatitis—Vincristine—colon cancer	0.00376	0.00376	CcSEcCtD
Cefprozil—Headache—Vincristine—colon cancer	0.00374	0.00374	CcSEcCtD
Cefprozil—Vomiting—Irinotecan—colon cancer	0.0037	0.0037	CcSEcCtD
Cefprozil—Dizziness—Fluorouracil—colon cancer	0.00369	0.00369	CcSEcCtD
Cefprozil—Rash—Irinotecan—colon cancer	0.00367	0.00367	CcSEcCtD
Cefprozil—Dermatitis—Irinotecan—colon cancer	0.00367	0.00367	CcSEcCtD
Cefprozil—Headache—Irinotecan—colon cancer	0.00365	0.00365	CcSEcCtD
Cefprozil—Erythema—Methotrexate—colon cancer	0.00355	0.00355	CcSEcCtD
Cefprozil—Nausea—Vincristine—colon cancer	0.00355	0.00355	CcSEcCtD
Cefprozil—Vomiting—Fluorouracil—colon cancer	0.00354	0.00354	CcSEcCtD
Cefprozil—Insomnia—Capecitabine—colon cancer	0.00352	0.00352	CcSEcCtD
Cefprozil—Rash—Fluorouracil—colon cancer	0.00351	0.00351	CcSEcCtD
Cefprozil—Dermatitis—Fluorouracil—colon cancer	0.00351	0.00351	CcSEcCtD
Cefprozil—Headache—Fluorouracil—colon cancer	0.00349	0.00349	CcSEcCtD
Cefprozil—Nausea—Irinotecan—colon cancer	0.00346	0.00346	CcSEcCtD
Cefprozil—Pain—Capecitabine—colon cancer	0.00333	0.00333	CcSEcCtD
Cefprozil—Nausea—Fluorouracil—colon cancer	0.00331	0.00331	CcSEcCtD
Cefprozil—Feeling abnormal—Capecitabine—colon cancer	0.00321	0.00321	CcSEcCtD
Cefprozil—Gastrointestinal pain—Capecitabine—colon cancer	0.00318	0.00318	CcSEcCtD
Cefprozil—Urticaria—Capecitabine—colon cancer	0.00309	0.00309	CcSEcCtD
Cefprozil—Abdominal pain—Capecitabine—colon cancer	0.00308	0.00308	CcSEcCtD
Cefprozil—Body temperature increased—Capecitabine—colon cancer	0.00308	0.00308	CcSEcCtD
Cefprozil—Convulsion—Methotrexate—colon cancer	0.00308	0.00308	CcSEcCtD
Cefprozil—Confusional state—Methotrexate—colon cancer	0.00292	0.00292	CcSEcCtD
Cefprozil—Anaphylactic shock—Methotrexate—colon cancer	0.0029	0.0029	CcSEcCtD
Cefprozil—Hypersensitivity—Capecitabine—colon cancer	0.00287	0.00287	CcSEcCtD
Cefprozil—Thrombocytopenia—Methotrexate—colon cancer	0.00284	0.00284	CcSEcCtD
Cefprozil—Pruritus—Capecitabine—colon cancer	0.00276	0.00276	CcSEcCtD
Cefprozil—Diarrhoea—Capecitabine—colon cancer	0.00266	0.00266	CcSEcCtD
Cefprozil—Insomnia—Methotrexate—colon cancer	0.00262	0.00262	CcSEcCtD
Cefprozil—Somnolence—Methotrexate—colon cancer	0.00258	0.00258	CcSEcCtD
Cefprozil—Dizziness—Capecitabine—colon cancer	0.00258	0.00258	CcSEcCtD
Cefprozil—Pain—Methotrexate—colon cancer	0.00248	0.00248	CcSEcCtD
Cefprozil—Vomiting—Capecitabine—colon cancer	0.00248	0.00248	CcSEcCtD
Cefprozil—Rash—Capecitabine—colon cancer	0.00246	0.00246	CcSEcCtD
Cefprozil—Dermatitis—Capecitabine—colon cancer	0.00245	0.00245	CcSEcCtD
Cefprozil—Headache—Capecitabine—colon cancer	0.00244	0.00244	CcSEcCtD
Cefprozil—Feeling abnormal—Methotrexate—colon cancer	0.00239	0.00239	CcSEcCtD
Cefprozil—Gastrointestinal pain—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Cefprozil—Nausea—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Cefprozil—Urticaria—Methotrexate—colon cancer	0.0023	0.0023	CcSEcCtD
Cefprozil—Body temperature increased—Methotrexate—colon cancer	0.00229	0.00229	CcSEcCtD
Cefprozil—Abdominal pain—Methotrexate—colon cancer	0.00229	0.00229	CcSEcCtD
Cefprozil—Hypersensitivity—Methotrexate—colon cancer	0.00214	0.00214	CcSEcCtD
Cefprozil—Pruritus—Methotrexate—colon cancer	0.00205	0.00205	CcSEcCtD
Cefprozil—Diarrhoea—Methotrexate—colon cancer	0.00198	0.00198	CcSEcCtD
Cefprozil—Dizziness—Methotrexate—colon cancer	0.00192	0.00192	CcSEcCtD
Cefprozil—Vomiting—Methotrexate—colon cancer	0.00184	0.00184	CcSEcCtD
Cefprozil—Rash—Methotrexate—colon cancer	0.00183	0.00183	CcSEcCtD
Cefprozil—Dermatitis—Methotrexate—colon cancer	0.00183	0.00183	CcSEcCtD
Cefprozil—Headache—Methotrexate—colon cancer	0.00182	0.00182	CcSEcCtD
Cefprozil—Nausea—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
